About the
News & EventsAlumni
& Giving
Make a Gift

News Release (Back to Menu)

Agenda Set for September 23 Patent Law and Pharmaceuticals Symposium

September 22, 2008 – 
Speakers at Rutgers School of Law–Newark’s second annual “Patent Law and Pharmaceuticals Symposium,” to be held at the law school on Tuesday, September 23, will address top-level issues affecting patent law and the drug industry. The symposium is co-hosted by the New Jersey Intellectual Property Association and sponsored by Weil, Gotshal & Manges LLP. The agenda follows:

Noon – 1:15 pm
Lunch, Opening Remarks, and Keynote Address
The Hon. Pauline Newman, U.S. Court of Appeals for the Federal Circuit

1:30 – 2:30 pm
“An Examination of the Proposed Local Patent Rules for the District of New Jersey”
The Hon. Stanley R. Chesler, U.S. District Judge for the District of New Jersey
Edward R. Reines, Esq., Partner, Weil, Gotshal & Manges LLP
Robert G. Shepherd, Esq., Managing Partner, Mathews, Shepherd, McKay & Bruneau, P.A., moderator

2:45 – 4:00 pm
“Do Patent Settlements Between Brand Name Companies and Their Generic Rivals Violate  the Antitrust Laws? An Exploration of Recent Trends and Legal Developments”
Daniel A. Crane, Associate Professor of Law, Cardozo School of Law
C. Scott Hemphill, Associate Professor of Law, Columbia Law School
Keith Sharfman, Professor of Law, Marquette Law School
Sabrina Safrin, Professor of Law, Rutgers School of Law–Newark, moderator

4:15 – 5:30 pm
“Views From Industry: Senior In-House Counsel Discuss the Patent Issues That Matter  Most to Pharma”
Henry Hadad, Vice President & Associate General Counsel, Intellectual Property, Schering-Plough Corporation
David Manspeizer, Vice President Intellectual Property and Associate General Counsel, Wyeth
Jeffrey N. Myers, Ph.D., Vice President and Assistant General Counsel, Intellectual Property Enforcement, Pfizer Inc.
Nicholas Groombridge, Adjunct Professor, Rutgers School of Law–Newark, moderator